MedPath

A study investigating the possibility and practicality of assessing and treating dizziness after traumatic brain injury

Not Applicable
Completed
Conditions
Benign paroxysmal positional vertigo
Ear, Nose and Throat
Registration Number
ISRCTN91943864
Lead Sponsor
Imperial College London
Brief Summary

2020 Protocol article in https://pubmed.ncbi.nlm.nih.gov/32944278/ protocol (added 21/09/2020) 2023 Interim results article in https://pubmed.ncbi.nlm.nih.gov/36592999/ Qualitative results on healthcare professionals' perceptions of barriers or facilitators (added 03/01/2023) 2024 Results article in https://doi.org/10.1136/bmjno-2023-000598 (added 31/05/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
75
Inclusion Criteria

Patient
1. Over the age of 18 years
2. Closed head injury as defined by CT imaging
3. Inpatient on major trauma or outlying ward
4. Able to give informed consent or consultee consent
5. Sufficient grasp of English to consent and complete outcome measures

Staff inclusion criteria:
1. Members of ward staff involved in the trial
2. Able to consent to an audio-recorded interview

Exclusion Criteria

Patients exclusion criteria:
1. History of previous or current substance abuse
2. Orthopaedic or vascular cervical spine instability
3. Pregnant
4.Glasgow Coma Score at assessment less than 14
5. Medically unstable
6. Current prescription of Phenytoin
7. Active psychiatric disease, including those with a current or past history of active psychotic disease but not those with a past history of psychiatric disease

Staff exclusion criteria:
Does not meet inclusion criteria

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Trial recruitment and retention rates measured at the end of the trial<br>2 .Acceptability and fidelity of the intervention examined at the end of the trial<br>3. Incidence of adverse events measured at the end of the trial
Secondary Outcome Measures
NameTimeMethod
1. Frequency of BPPV measured at baseline, 4 and 12 weeks<br>2. Dizziness handicap measured using Dizziness handicap inventory at baseline, 4 and 12 weeks<br>3. Balance confidence measured using the Activities specific balance confidence scale at baseline 4 and 12 weeks<br>4. Mood measured using the hospital anxiety and depression scale at baseline, 4 and 12 weeks<br>5. Static and dynamic balance measured using the mCTSIB and mDGI at baseline and 4 and 12 weeks<br>6. Quality of life measured using quality of life after brain injury questionnaire at 4 and 12 weeks<br>7. Brain injury recovery measured using the glasgow outcome scale extended at 4 and 12 weeks
© Copyright 2025. All Rights Reserved by MedPath